Bazlitoran Uses, Dosage, Side Effects and more
Bazlitoran is under investigation in clinical trial NCT02092909 (Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia).
| Attribute | Details |
|---|---|
| Trade Name | Bazlitoran |
| Generic | Bazlitoran |
| Bazlitoran Other Names | Bazlitoran |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
